Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Apr;71(4):884–891. doi: 10.1172/JCI110842

Interactions between 8-L-arginine vasopressin and prostaglandin E2 in human mononuclear phagocytes.

R Locher, W Vetter, L H Block
PMCID: PMC436945  PMID: 6300191

Abstract

The effect of 8-L-arginine vasopressin (AVP) on biosynthesis of prostaglandins in human mononuclear phagocytes was examined. AVP, oxytocin, and deamino-(8-D-arginine) vasopressin (dDAVP) affected prostaglandin biosynthesis in a rank order that parallels their pressor but not antidiuretic activity (AVP greater than oxytocin greater than dDAVP). Radioimmunoassay, incorporation studies using [14C]arachidonic acid and radiometric thin-layer chromatography, revealed prostaglandin E2 (PGE2) to be the only prostaglandin synthesized by the mononuclear phagocytes. While high concentrations of PGE2 elevated cytoplasmic levels of cyclic AMP by five- to sevenfold above basal values, low concentrations of PGE2 that are released by the cells in the presence of AVP failed to increase cyclic AMP content in the cells. However, PGE2 at concentrations that do not alter cyclic AMP levels markedly interferes with the activity of AVP. This effect is, however, very time dependent. Addition of PGE2 to the cells 30 min before AVP, was followed by a period of unresponsiveness to the hormone that lasts at least 30 min. Pretreatment of the cells with indomethacin enhanced the AVP-mediated accumulation of intracellular cyclic AMP level. PGE2 did not modify [3H]AVP binding, indicating that its inhibitory effect on the activity of the peptide is not due to downregulation of vasopressin receptors.

Full text

PDF
884

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  2. Beck N. P., Kaneko T., Zor U., Field J. B., Davis B. B. Effects of vasopressin and prostaglandin E 1 on the adenyl cyclase-cyclic 3',5'-adenosine monophosphate system of the renal medulla of the rat. J Clin Invest. 1971 Dec;50(12):2461–2465. doi: 10.1172/JCI106746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beck T. R., Hassid A., Dunn M. J. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture. J Pharmacol Exp Ther. 1980 Oct;215(1):15–19. [PubMed] [Google Scholar]
  4. Block L. H., Locher R., Tenschert W., Siegenthaler W., Hofmann T., Mettler E., Vetter W. 125I-8-L-arginine vasopressin binding to human mononuclear phagocytes. J Clin Invest. 1981 Aug;68(2):374–381. doi: 10.1172/JCI110265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burch R. M., Knapp D. R., Halushka P. V. Vasopressin stimulates thromboxane synthesis in the toad urinary bladder: effects of imidazole. J Pharmacol Exp Ther. 1979 Sep;210(3):344–348. [PubMed] [Google Scholar]
  6. Dunn M. J., Hood V. L. Prostaglandins and the kidney. Am J Physiol. 1977 Sep;233(3):169–184. doi: 10.1152/ajprenal.1977.233.3.F169. [DOI] [PubMed] [Google Scholar]
  7. Handler J. S. Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water. Kidney Int. 1981 Jun;19(6):831–838. doi: 10.1038/ki.1981.87. [DOI] [PubMed] [Google Scholar]
  8. Kalisker A., Dyer D. C. In vitro release of prostaglandins from the renal medulla. Eur J Pharmacol. 1972 Sep;19(3):305–309. doi: 10.1016/0014-2999(72)90095-7. [DOI] [PubMed] [Google Scholar]
  9. Kurland J. I., Bockman R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med. 1978 Mar 1;147(3):952–957. doi: 10.1084/jem.147.3.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Li C. Y., Lam K. W., Yam L. T. Esterases in human leukocytes. J Histochem Cytochem. 1973 Jan;21(1):1–12. doi: 10.1177/21.1.1. [DOI] [PubMed] [Google Scholar]
  12. Lowbridge J., Manning M., Haldar J., Sawyer W. H. [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),4-valine,-8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin. J Med Chem. 1978 Mar;21(3):313–315. doi: 10.1021/jm00201a019. [DOI] [PubMed] [Google Scholar]
  13. Lum G. M., Aisenbrey G. A., Dunn M. J., Berl T., Schrier R. W., McDonald K. M. In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. J Clin Invest. 1977 Jan;59(1):8–13. doi: 10.1172/JCI108624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  15. ORLOFF J., HANDLER J. S., BERGSTROM S. EFFECT OF PROSTAGLANDIN (PGE-1) ON THE PERMEABILITY RESPONSE OF TOAD BLADDER TO VASOPRESSIN, THEOPHYLLINE AND ADENOSINE 3',5'-MONOPHOSPHATE. Nature. 1965 Jan 23;205:397–398. doi: 10.1038/205397a0. [DOI] [PubMed] [Google Scholar]
  16. ORLOFF J., HANDLER J. S. THE CELLULAR MODE OF ACTION OF ANTIDIURETIC HORMONE. Am J Med. 1964 May;36:686–697. doi: 10.1016/0002-9343(64)90180-9. [DOI] [PubMed] [Google Scholar]
  17. Omachi R. S., Robbie D. E., Handler J. S., Orloff J. Effects of ADH and other agents on cyclic AMP accumulation in toad bladder epithelium. Am J Physiol. 1974 May;226(5):1152–1157. doi: 10.1152/ajplegacy.1974.226.5.1152. [DOI] [PubMed] [Google Scholar]
  18. Sawyer W. H., Acosta M., Manning M. Structural changes in the arginine vasopressin molecule that prolong its antidiuretic action. Endocrinology. 1974 Jul;95(1):140–149. doi: 10.1210/endo-95-1-140. [DOI] [PubMed] [Google Scholar]
  19. Zusman R. M., Keiser H. R., Handler J. S. Effect of adrenal steroids on vasopressin-stimulated PGE synthesis and water flow. Am J Physiol. 1978 Jun;234(6):F532–F540. doi: 10.1152/ajprenal.1978.234.6.F532. [DOI] [PubMed] [Google Scholar]
  20. Zusman R. M., Keiser H. R., Handler J. S. Vasopressin-stimulated prostaglandin E biosynthesis in the toad urinary bladder. Effect of water flow. J Clin Invest. 1977 Dec;60(6):1339–1347. doi: 10.1172/JCI108893. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES